Therapeutic Effects of Endoscopic Ablation of Hunner Lesions in Interstitial Cystitis/ Bladder Pain Syndrome Patients
NCT03468530 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 442
Last updated 2025-07-22
Summary
efficacy of endoscopic ablation of Hunner lesions in patients with IC/BPS and the characteristics of HLs based on a long-term follow-up
Conditions
- Interstitial Cystitis
Interventions
- PROCEDURE
-
Transurethral ablation
transurethral resection and/or coagulation with a bipolar loop under spinal or general anesthesia
Sponsors & Collaborators
-
Samsung Medical Center
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-08-01
- Primary Completion
- 2013-12-31
- Completion
- 2025-07-18
Countries
- South Korea
Study Locations
More Related Trials
-
Evaluation of Response to Use of Intravesical Ozone Gas in Interstitial Cystitis /Bladder Pain Syndrome
NCT04789135 ·Status: UNKNOWN ·Phase: PHASE2
-
Low Energy Shock Wave for the Treatment of Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS)
NCT03619486 ·Status: COMPLETED ·Phase: NA
-
Assessing the Effectiveness and Safety of Interferon Bladder Infusion for the Treatment of Interstitial Cystitis
NCT05912946 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
The Efficacy of Biomarker in Patient With Interstitial Cystitis/Painful Bladder Syndrome
NCT01985880 ·Status: COMPLETED
-
Bladder Thermal Distention for Patients With Interstitial Cystitis / Painful Bladder Syndrome
NCT01838486 ·Status: UNKNOWN ·Phase: NA
-
A Study to Determine the Role of Toll-like Receptor-4 Expression in Patients With Interstitial Cystitis/Bladder Pain Syndrome
NCT02868775 ·Status: UNKNOWN
-
Clinical Features and Histologic Findings in Bladder Pain Syndrome/Interstitial Cystitis
NCT03069053 ·Status: COMPLETED
-
Changes in Inflammatory and Contractile Protein Expression in Patients With Painful Bladder Syndrome/IC.
NCT00775281 ·Status: COMPLETED
-
A Safety and Efficacy Study of LiRIS® in Females With Interstitial Cystitis With Hunner's Lesions
NCT02395042 ·Status: COMPLETED ·Phase: PHASE2
-
Genetic and Histopathologic Characteristics of Interstitial Cystitis
NCT03523559 ·Status: COMPLETED
-
A Safety, Tolerability and Preliminary Efficacy Study of LiRIS® 400 mg in Women With Interstitial Cystitis (IC) and Hunner's Lesions
NCT01879683 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Safety Study of Uracyst to Treat Interstitial Cystitis/Painful Bladder Syndrome
NCT00919113 ·Status: COMPLETED ·Phase: PHASE2
-
Diagnosis of Bladder Pain Syndrome / Interstitial Cystitis
NCT03023241 ·Status: COMPLETED ·Phase: NA
-
Correlations of 3D Urethral and Paraurethral Sonographic Findings With Urodynamic Studies, Lower Urinary Tract Symptoms & Sexual Dysfunction in Female Patients With Lower Urinary Tract Symptoms.
NCT01884753 ·Status: COMPLETED
-
Efficacy Study of Adalimumab to Treat Interstitial Cystitis
NCT01295814 ·Status: COMPLETED ·Phase: PHASE3
-
Intravesical Liposomes for Ulcerative Cystitis
NCT01083979 ·Status: COMPLETED ·Phase: NA
-
Intravesical Platelet-rich Plasma Injection in Patients With Interstitial Cystitis/Bladder-A Retrospective Study
NCT06339645 ·Status: NOT_YET_RECRUITING
-
Interstitial Cystitis (IC)-Like Findings With Hydrodistension
NCT02547298 ·Status: TERMINATED
-
An Effectiveness And Safety Study Of PD 0299685 For The Treatment Of Symptoms Associated With Interstitial Cystitis
NCT00739739 ·Status: COMPLETED ·Phase: PHASE2
-
A Pilot Clinical Investigation of the Efficacy and Safety of Uracyst® Versus Placebo in Patients With Interstitial Cystitis/Painful Bladder Syndrome.
NCT00527917 ·Status: COMPLETED ·Phase: PHASE2
-
A Pilot Study of the Effects of Mirabegron on Symptoms in Patients With Interstitial Cystitis
NCT02787083 ·Status: TERMINATED ·Phase: PHASE3
-
Quantitative Studies of Urinary Bladder Sensation
NCT00903435 ·Status: COMPLETED
-
Motor Cortical Neuromodulation in Women With Interstitial Cystitis/Bladder Pain Syndrome
NCT04734847 ·Status: RECRUITING ·Phase: NA
-
Cyclosporine in Interstitial Cystitis: Efficacy, Safety and Mechanism of Action
NCT01990898 ·Status: COMPLETED ·Phase: PHASE2
-
Study Evaluating Orally Administered ERB-041 in Subjects With Active Interstitial Cystitis
NCT00275379 ·Status: WITHDRAWN ·Phase: NA